Companies Cryptocurrencies
9 Meters Biopharma Inc
9 Meters Biopharma Inc
Exchange: NasdaqGS
IPO Date: 08/07/2016
CEO: Mr. John Temperato
Biotechnology Healthcare 🔗
  • NMTR
  • 0.2205
  • 57133096
    market cap
  • 0.00680001
If you bought

shares of 9 Meters Biopharma Inc (NMTR) on
You would have made
Old Price $12 Current Price $12

9 Meters Biopharma, Inc., formerly Innovate Biopharmaceuticals, Inc., is a gastrointestinal platform company. The Company is focused on developing treatments for patients with rare disorders and unmet needs. Its pipeline includes drug candidates for short bowel syndrome and celiac disease. Its pipeline includes NM-002, Larazotide, NM-003 and NM-004. NM-002 is a long-acting injectable GLP-1 analogue for short bowel syndrome (SBS). Larazotide is an orally administered, gut-restricted tight-junction regulator for celiac disease. NM-003 is a GLP-2 analogue, under orphan indication selection. NM -004 is an immunomodulator, granted pediatric orphan designation in ulcerative colitis.

Address: 8480 Honeycutt Rd Ste 120 Raleigh NORTH CAROLINA 27615

Stay updated.